将ARCO股骨头坏死临床实践指南整合到诊断与管理:四个示例病例场景
本文通过四个代表性病例展示ARCO股骨头坏死临床实践指南在临床实践中的具体应用,涵盖从无症状小病灶的观察、症状性塌陷前病变的髓芯减压联合骨髓浓缩物增强、双侧病变的个体化决策,到根据年龄、病灶大小和症状决定观察或干预的决策过程。
要点
- 小而无症状、塌陷风险低的病灶可考虑MRI诊断并观察。
- 症状性塌陷前病变可采用髓芯减压联合骨髓浓缩物增强。
- 年轻双侧ONFH患者需个体化选择保髋与全髋关节置换。
核心结论
- ARCO股骨头坏死临床实践指南为诊断、风险分层和治疗选择提供了实用框架。
- 应用指南推荐可促进广泛临床场景下的循证和以患者为中心的决策。
研究设计与样本
- 本文为指南应用说明,通过选择四个相关临床病例来展示ARCO指南推荐在多种ONFH表现中的应用。
- 病例选择突出影像学选择、症状评估、塌陷风险估计、观察依据、保髋技术使用和全髋关节置换考虑等诊断和治疗决策。
主要发现
- 病例1展示MRI在小而无症状、塌陷风险低病灶诊断中的价值及观察的适宜性。
- 病例2展示髓芯减压联合骨髓浓缩物增强可用于治疗症状性塌陷前病变。
- 病例3展示年轻双侧ONFH患者对侧塌陷前病变需保髋治疗、一侧已塌陷需THA的决策过程。
- 病例4展示患者年龄、病灶大小和症状状态影响无症状病变选择观察而非干预的决策。
临床怎么用
- 临床中可依据ARCO指南对ONFH患者进行诊断、风险分层和治疗选择。
- 对无症状小病灶可考虑MRI诊断并观察,对症状性塌陷前病变可考虑髓芯减压联合骨髓浓缩物增强。
- 对双侧ONFH年轻患者,可结合病灶状态个体化选择保髋或THA。
- 对无症状病变,可结合年龄、病灶大小和症状状态决定观察或干预。
局限性
- 本文仅说明指南应用,不讨论治疗结局,治疗结局在指南本身中讨论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Treatment choices for osteonecrosis of the femoral head (ONFH) are based on the patient's age, risk of collapse, lesion size, symptoms, and disease stage. To our knowledge, this represents the first international, evidence-based clinical practice guideline (CPG) developed specifically for the diagnosis and treatment of nontraumatic ONFH, which was recently released by the Association Research Circulation Osseous (ARCO). The CPG offers recommendations that are supported by evidence, but their practical implementation in day-to-day clinical practice may be less intuitive. These case scenarios illustrate the application of the CPG only and do not discuss treatment outcomes, which are discussed in the CPG itself. METHODS: To illustrate how ARCO CPG recommendations can be applied to a range of ONFH presentations, four relevant clinical cases were chosen. The selection of imaging, evaluation of symptoms, estimation of collapse risk, grounds for observation, use of joint-preserving techniques, and consideration of total hip arthroplasty (THA) are all important diagnostic and therapy choices that are highlighted in each case. RESULTS: For small, asymptomatic lesions with little chance of collapse, Case 1 illustrates the value of magnetic resonance imaging in the diagnosis and the suitability of observation. Case 2 shows how core decompression and bone marrow concentrate augmentation can be used to treat symptomatic pre-collapse disease. Case 3 illustrates the decision-making process for a young patient who has bilateral ONFH and needs joint-preserving therapy for the contralateral pre-collapse lesion and THA for one hip with collapse. Case 4 illustrates how patient age, lesion size, and symptom status affect the decision to choose observation over intervention for asymptomatic illness. CONCLUSION: The ARCO CPG provides a practical framework for diagnosis, risk stratification, and treatment selection in patients who have ONFH. Application of the guideline recommendations can facilitate evidence-based and patient-centered decision-making across a broad spectrum of clinical scenarios.
引用
- Thomas G, Mirzaei A, Mont MA, et al. Integrating the Association Research Circulation Osseous Clinical Practice Guideline into the Diagnosis and Management of Osteonecrosis of the Femoral Head: Four Illustrative Case Scenarios. J Arthroplasty. 2026. PMID: 42843688. doi:10.1016/j.arth.2026.09.041
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。